oral chemotherapeutic agents — United Healthcare
non-oncology indications recognized in product labeling, a published compendium (e.g., Micromedex, Clinical Pharmacology), or demonstrated as proven in peer reviewed medical literature
Initial criteria
- Patient is under the age of 19 years OR
- Drug is recognized for treatment of the cancer indication by the NCCN Drugs and Biologics Compendium with a Category of Evidence and Consensus of 1, 2A, or 2B OR
- Patient is receiving treatment for a non-oncology indication that is recognized in the product labeling, a published compendium (e.g., Micromedex, Clinical Pharmacology), or is demonstrated as proven in the peer reviewed medical literature
Approval duration
12 months